AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial
Rick B. Vega, Pavlo Garkaviy, Jane Knöchel, April Barbour, Anna Rudvik, Johanna Laru, Lee Twaddle, Michael McCarthy, Jaya Birgitte Rosenmeier
Topics & Concepts
PCSK9PlaceboFamilial hypercholesterolemiaSingle blindMedicineDouble blindRandomized controlled trialInternal medicinePharmacologyCholesterolLDL receptorPathologyLipoproteinAlternative medicineLipoproteins and Cardiovascular HealthComputational Drug Discovery Methods